id	sid	tid	token	lemma	pos
cord-253196-et1ekgdl	1	1	key	key	JJ
cord-253196-et1ekgdl	1	2	:	:	:
cord-253196-et1ekgdl	1	3	cord-253196-et1ekgdl	cord-253196-et1ekgdl	CD
cord-253196-et1ekgdl	1	4	authors	author	NNS
cord-253196-et1ekgdl	1	5	:	:	:
cord-253196-et1ekgdl	1	6	Yazdany	Yazdany	NNP
cord-253196-et1ekgdl	1	7	,	,	,
cord-253196-et1ekgdl	1	8	Jinoos	Jinoos	NNP
cord-253196-et1ekgdl	1	9	;	;	:
cord-253196-et1ekgdl	1	10	Kim	Kim	NNP
cord-253196-et1ekgdl	1	11	,	,	,
cord-253196-et1ekgdl	1	12	Alfred	Alfred	NNP
cord-253196-et1ekgdl	1	13	H.J.	H.J.	NNP
cord-253196-et1ekgdl	1	14	title	title	NN
cord-253196-et1ekgdl	1	15	:	:	:
cord-253196-et1ekgdl	1	16	Use	Use	NNP
cord-253196-et1ekgdl	1	17	of	of	IN
cord-253196-et1ekgdl	1	18	Hydroxychloroquine	Hydroxychloroquine	NNP
cord-253196-et1ekgdl	1	19	and	and	CC
cord-253196-et1ekgdl	1	20	Chloroquine	Chloroquine	NNP
cord-253196-et1ekgdl	1	21	During	during	IN
cord-253196-et1ekgdl	1	22	the	the	DT
cord-253196-et1ekgdl	1	23	COVID-19	COVID-19	NNP
cord-253196-et1ekgdl	1	24	Pandemic	Pandemic	NNP
cord-253196-et1ekgdl	1	25	:	:	:
cord-253196-et1ekgdl	2	1	What	what	WP
cord-253196-et1ekgdl	2	2	Every	every	DT
cord-253196-et1ekgdl	2	3	Clinician	clinician	NN
cord-253196-et1ekgdl	2	4	Should	Should	MD
cord-253196-et1ekgdl	2	5	Know	know	VB
cord-253196-et1ekgdl	2	6	date	date	NN
cord-253196-et1ekgdl	3	1	:	:	:
cord-253196-et1ekgdl	3	2	2020	2020	CD
cord-253196-et1ekgdl	3	3	-	-	HYPH
cord-253196-et1ekgdl	3	4	03	03	CD
cord-253196-et1ekgdl	3	5	-	-	HYPH
cord-253196-et1ekgdl	3	6	31	31	CD
cord-253196-et1ekgdl	3	7	journal	journal	NN
cord-253196-et1ekgdl	3	8	:	:	:
cord-253196-et1ekgdl	4	1	Ann	Ann	NNP
cord-253196-et1ekgdl	4	2	Intern	Intern	NNP
cord-253196-et1ekgdl	4	3	Med	Med	NNP
cord-253196-et1ekgdl	4	4	DOI	DOI	NNP
cord-253196-et1ekgdl	4	5	:	:	:
cord-253196-et1ekgdl	5	1	10.7326	10.7326	CD
cord-253196-et1ekgdl	5	2	/	/	SYM
cord-253196-et1ekgdl	5	3	m20	m20	CD
cord-253196-et1ekgdl	5	4	-	-	SYM
cord-253196-et1ekgdl	5	5	1334	1334	CD
cord-253196-et1ekgdl	5	6	sha	sha	NN
cord-253196-et1ekgdl	5	7	:	:	:
cord-253196-et1ekgdl	5	8	a6f941a2724e5e6c3d00f3fbc570182f1a8188f4	a6f941a2724e5e6c3d00f3fbc570182f1a8188f4	NNP
cord-253196-et1ekgdl	5	9	doc_id	doc_id	CD
cord-253196-et1ekgdl	5	10	:	:	:
cord-253196-et1ekgdl	5	11	253196	253196	CD
cord-253196-et1ekgdl	5	12	cord_uid	cord_uid	NNS
cord-253196-et1ekgdl	5	13	:	:	:
cord-253196-et1ekgdl	6	1	et1ekgdl	et1ekgdl	.
cord-253196-et1ekgdl	7	1	Two	two	CD
cord-253196-et1ekgdl	7	2	medications	medication	NNS
cord-253196-et1ekgdl	7	3	often	often	RB
cord-253196-et1ekgdl	7	4	used	use	VBN
cord-253196-et1ekgdl	7	5	for	for	IN
cord-253196-et1ekgdl	7	6	treatment	treatment	NN
cord-253196-et1ekgdl	7	7	of	of	IN
cord-253196-et1ekgdl	7	8	immune	immune	NN
cord-253196-et1ekgdl	7	9	-	-	HYPH
cord-253196-et1ekgdl	7	10	mediated	mediate	VBN
cord-253196-et1ekgdl	7	11	conditions	condition	NNS
cord-253196-et1ekgdl	7	12	,	,	,
cord-253196-et1ekgdl	7	13	hydroxychloroquine	hydroxychloroquine	NN
cord-253196-et1ekgdl	7	14	and	and	CC
cord-253196-et1ekgdl	7	15	chloroquine	chloroquine	NNP
cord-253196-et1ekgdl	7	16	,	,	,
cord-253196-et1ekgdl	7	17	have	have	VBP
cord-253196-et1ekgdl	7	18	recently	recently	RB
cord-253196-et1ekgdl	7	19	attracted	attract	VBN
cord-253196-et1ekgdl	7	20	widespread	widespread	JJ
cord-253196-et1ekgdl	7	21	interest	interest	NN
cord-253196-et1ekgdl	7	22	as	as	IN
cord-253196-et1ekgdl	7	23	potential	potential	JJ
cord-253196-et1ekgdl	7	24	therapies	therapy	NNS
cord-253196-et1ekgdl	7	25	for	for	IN
cord-253196-et1ekgdl	7	26	coronavirus	coronavirus	NN
cord-253196-et1ekgdl	7	27	disease	disease	NN
cord-253196-et1ekgdl	7	28	2019	2019	CD
cord-253196-et1ekgdl	7	29	.	.	.
cord-253196-et1ekgdl	8	1	The	the	DT
cord-253196-et1ekgdl	8	2	authors	author	NNS
cord-253196-et1ekgdl	8	3	of	of	IN
cord-253196-et1ekgdl	8	4	this	this	DT
cord-253196-et1ekgdl	8	5	commentary	commentary	NN
cord-253196-et1ekgdl	8	6	provide	provide	VBP
cord-253196-et1ekgdl	8	7	guidance	guidance	NN
cord-253196-et1ekgdl	8	8	for	for	IN
cord-253196-et1ekgdl	8	9	clinical	clinical	JJ
cord-253196-et1ekgdl	8	10	decision	decision	NN
cord-253196-et1ekgdl	8	11	making	make	VBG
cord-253196-et1ekgdl	8	12	for	for	IN
cord-253196-et1ekgdl	8	13	patients	patient	NNS
cord-253196-et1ekgdl	8	14	with	with	IN
cord-253196-et1ekgdl	8	15	coronavirus	coronavirus	NN
cord-253196-et1ekgdl	8	16	disease	disease	NN
cord-253196-et1ekgdl	8	17	2019	2019	CD
cord-253196-et1ekgdl	8	18	as	as	RB
cord-253196-et1ekgdl	8	19	well	well	RB
cord-253196-et1ekgdl	8	20	as	as	IN
cord-253196-et1ekgdl	8	21	for	for	IN
cord-253196-et1ekgdl	8	22	patients	patient	NNS
cord-253196-et1ekgdl	8	23	with	with	IN
cord-253196-et1ekgdl	8	24	rheumatologic	rheumatologic	JJ
cord-253196-et1ekgdl	8	25	conditions	condition	NNS
cord-253196-et1ekgdl	8	26	,	,	,
cord-253196-et1ekgdl	8	27	such	such	JJ
cord-253196-et1ekgdl	8	28	as	as	IN
cord-253196-et1ekgdl	8	29	systemic	systemic	JJ
cord-253196-et1ekgdl	8	30	lupus	lupus	NN
cord-253196-et1ekgdl	8	31	erythematosus	erythematosus	NN
cord-253196-et1ekgdl	8	32	and	and	CC
cord-253196-et1ekgdl	8	33	rheumatoid	rheumatoid	NN
cord-253196-et1ekgdl	8	34	arthritis	arthritis	NN
cord-253196-et1ekgdl	9	1	I	-PRON-	PRP
cord-253196-et1ekgdl	9	2	n	n	VBP
cord-253196-et1ekgdl	9	3	the	the	DT
cord-253196-et1ekgdl	9	4	desperate	desperate	JJ
cord-253196-et1ekgdl	9	5	search	search	NN
cord-253196-et1ekgdl	9	6	to	to	TO
cord-253196-et1ekgdl	9	7	find	find	VB
cord-253196-et1ekgdl	9	8	effective	effective	JJ
cord-253196-et1ekgdl	9	9	treatments	treatment	NNS
cord-253196-et1ekgdl	9	10	for	for	IN
cord-253196-et1ekgdl	9	11	coronavirus	coronavirus	NN
cord-253196-et1ekgdl	9	12	disease	disease	NN
cord-253196-et1ekgdl	9	13	2019	2019	CD
cord-253196-et1ekgdl	9	14	(	(	-LRB-
cord-253196-et1ekgdl	9	15	COVID-19	COVID-19	NNP
cord-253196-et1ekgdl	9	16	)	)	-RRB-
cord-253196-et1ekgdl	9	17	,	,	.
cord-253196-et1ekgdl	10	1	2	2	CD
cord-253196-et1ekgdl	10	2	generic	generic	JJ
cord-253196-et1ekgdl	10	3	drugs	drug	NNS
cord-253196-et1ekgdl	10	4	,	,	,
cord-253196-et1ekgdl	10	5	used	use	VBN
cord-253196-et1ekgdl	10	6	largely	largely	RB
cord-253196-et1ekgdl	10	7	by	by	IN
cord-253196-et1ekgdl	10	8	rheumatologists	rheumatologist	NNS
cord-253196-et1ekgdl	10	9	and	and	CC
cord-253196-et1ekgdl	10	10	dermatologists	dermatologist	NNS
cord-253196-et1ekgdl	10	11	to	to	TO
cord-253196-et1ekgdl	10	12	treat	treat	VB
cord-253196-et1ekgdl	10	13	immune	immune	NN
cord-253196-et1ekgdl	10	14	-	-	HYPH
cord-253196-et1ekgdl	10	15	mediated	mediate	VBN
cord-253196-et1ekgdl	10	16	diseases	disease	NNS
cord-253196-et1ekgdl	10	17	,	,	,
cord-253196-et1ekgdl	10	18	have	have	VBP
cord-253196-et1ekgdl	10	19	entered	enter	VBN
cord-253196-et1ekgdl	10	20	the	the	DT
cord-253196-et1ekgdl	10	21	spotlight	spotlight	NN
cord-253196-et1ekgdl	10	22	.	.	.
cord-253196-et1ekgdl	11	1	The	the	DT
cord-253196-et1ekgdl	11	2	antimalarials	antimalarial	NNS
cord-253196-et1ekgdl	11	3	hydroxychloroquine	hydroxychloroquine	NN
cord-253196-et1ekgdl	11	4	(	(	-LRB-
cord-253196-et1ekgdl	11	5	HCQ	HCQ	NNP
cord-253196-et1ekgdl	11	6	)	)	-RRB-
cord-253196-et1ekgdl	11	7	and	and	CC
cord-253196-et1ekgdl	11	8	chloroquine	chloroquine	NN
cord-253196-et1ekgdl	11	9	(	(	-LRB-
cord-253196-et1ekgdl	11	10	CQ	CQ	NNP
cord-253196-et1ekgdl	11	11	)	)	-RRB-
cord-253196-et1ekgdl	11	12	have	have	VBP
cord-253196-et1ekgdl	11	13	demonstrated	demonstrate	VBN
cord-253196-et1ekgdl	11	14	antiviral	antiviral	JJ
cord-253196-et1ekgdl	11	15	activity	activity	NN
cord-253196-et1ekgdl	11	16	against	against	IN
cord-253196-et1ekgdl	11	17	severe	severe	JJ
cord-253196-et1ekgdl	11	18	acute	acute	JJ
cord-253196-et1ekgdl	11	19	respiratory	respiratory	JJ
cord-253196-et1ekgdl	11	20	syndromecoronavirus	syndromecoronavirus	NNP
cord-253196-et1ekgdl	11	21	2	2	CD
cord-253196-et1ekgdl	12	1	(	(	-LRB-
cord-253196-et1ekgdl	12	2	SARS	SARS	NNP
cord-253196-et1ekgdl	12	3	-	-	HYPH
cord-253196-et1ekgdl	12	4	CoV-2	CoV-2	NNP
cord-253196-et1ekgdl	12	5	)	)	-RRB-
cord-253196-et1ekgdl	12	6	in	in	IN
cord-253196-et1ekgdl	12	7	vitro	vitro	FW
cord-253196-et1ekgdl	12	8	and	and	CC
cord-253196-et1ekgdl	12	9	in	in	IN
cord-253196-et1ekgdl	12	10	small	small	JJ
cord-253196-et1ekgdl	12	11	,	,	,
cord-253196-et1ekgdl	12	12	poorly	poorly	RB
cord-253196-et1ekgdl	12	13	controlled	control	VBN
cord-253196-et1ekgdl	12	14	or	or	CC
cord-253196-et1ekgdl	12	15	uncontrolled	uncontrolled	JJ
cord-253196-et1ekgdl	12	16	clinical	clinical	JJ
cord-253196-et1ekgdl	12	17	studies	study	NNS
cord-253196-et1ekgdl	12	18	(	(	-LRB-
cord-253196-et1ekgdl	12	19	1	1	CD
cord-253196-et1ekgdl	12	20	)	)	-RRB-
cord-253196-et1ekgdl	13	1	(	(	-LRB-
cord-253196-et1ekgdl	13	2	2	2	LS
cord-253196-et1ekgdl	13	3	)	)	-RRB-
cord-253196-et1ekgdl	13	4	(	(	-LRB-
cord-253196-et1ekgdl	13	5	3	3	CD
cord-253196-et1ekgdl	13	6	)	)	-RRB-
cord-253196-et1ekgdl	13	7	.	.	.
cord-253196-et1ekgdl	14	1	Normally	normally	RB
cord-253196-et1ekgdl	14	2	,	,	,
cord-253196-et1ekgdl	14	3	such	such	JJ
cord-253196-et1ekgdl	14	4	research	research	NN
cord-253196-et1ekgdl	14	5	would	would	MD
cord-253196-et1ekgdl	14	6	be	be	VB
cord-253196-et1ekgdl	14	7	deemed	deem	VBN
cord-253196-et1ekgdl	14	8	hypothesisgenerating	hypothesisgenerating	NN
cord-253196-et1ekgdl	14	9	at	at	IN
cord-253196-et1ekgdl	14	10	best	good	JJS
cord-253196-et1ekgdl	14	11	.	.	.
cord-253196-et1ekgdl	15	1	A	a	DT
cord-253196-et1ekgdl	15	2	tweet	tweet	NN
cord-253196-et1ekgdl	15	3	by	by	IN
cord-253196-et1ekgdl	15	4	President	President	NNP
cord-253196-et1ekgdl	15	5	Trump	Trump	NNP
cord-253196-et1ekgdl	15	6	on	on	IN
cord-253196-et1ekgdl	15	7	21	21	CD
cord-253196-et1ekgdl	15	8	March	March	NNP
cord-253196-et1ekgdl	15	9	2020	2020	CD
cord-253196-et1ekgdl	15	10	claiming	claim	VBG
cord-253196-et1ekgdl	15	11	that	that	IN
cord-253196-et1ekgdl	15	12	the	the	DT
cord-253196-et1ekgdl	15	13	combination	combination	NN
cord-253196-et1ekgdl	15	14	of	of	IN
cord-253196-et1ekgdl	15	15	HCQ	HCQ	NNP
cord-253196-et1ekgdl	15	16	and	and	CC
cord-253196-et1ekgdl	15	17	azithromycin	azithromycin	NNP
cord-253196-et1ekgdl	15	18	"	"	''
cord-253196-et1ekgdl	15	19	ha[s	ha[s	ADD
cord-253196-et1ekgdl	15	20	]	]	-RRB-
cord-253196-et1ekgdl	16	1	a	a	DT
cord-253196-et1ekgdl	16	2	real	real	JJ
cord-253196-et1ekgdl	16	3	chance	chance	NN
cord-253196-et1ekgdl	16	4	to	to	TO
cord-253196-et1ekgdl	16	5	be	be	VB
cord-253196-et1ekgdl	16	6	one	one	CD
cord-253196-et1ekgdl	16	7	of	of	IN
cord-253196-et1ekgdl	16	8	the	the	DT
cord-253196-et1ekgdl	16	9	biggest	big	JJS
cord-253196-et1ekgdl	16	10	game	game	NN
cord-253196-et1ekgdl	16	11	changers	changer	NNS
cord-253196-et1ekgdl	16	12	in	in	IN
cord-253196-et1ekgdl	16	13	the	the	DT
cord-253196-et1ekgdl	16	14	history	history	NN
cord-253196-et1ekgdl	16	15	of	of	IN
cord-253196-et1ekgdl	16	16	medicine	medicine	NN
cord-253196-et1ekgdl	16	17	"	"	''
cord-253196-et1ekgdl	16	18	accelerated	accelerate	VBD
cord-253196-et1ekgdl	16	19	a	a	DT
cord-253196-et1ekgdl	16	20	worldwide	worldwide	JJ
cord-253196-et1ekgdl	16	21	run	run	NN
cord-253196-et1ekgdl	16	22	on	on	IN
cord-253196-et1ekgdl	16	23	the	the	DT
cord-253196-et1ekgdl	16	24	drugs	drug	NNS
cord-253196-et1ekgdl	16	25	,	,	,
cord-253196-et1ekgdl	16	26	with	with	IN
cord-253196-et1ekgdl	16	27	pharmacies	pharmacy	NNS
cord-253196-et1ekgdl	16	28	reporting	report	VBG
cord-253196-et1ekgdl	16	29	shortages	shortage	NNS
cord-253196-et1ekgdl	16	30	within	within	IN
cord-253196-et1ekgdl	16	31	24	24	CD
cord-253196-et1ekgdl	16	32	hours	hour	NNS
cord-253196-et1ekgdl	16	33	.	.	.
cord-253196-et1ekgdl	17	1	Here	here	RB
cord-253196-et1ekgdl	17	2	,	,	,
cord-253196-et1ekgdl	17	3	we	-PRON-	PRP
cord-253196-et1ekgdl	17	4	try	try	VBP
cord-253196-et1ekgdl	17	5	to	to	TO
cord-253196-et1ekgdl	17	6	provide	provide	VB
cord-253196-et1ekgdl	17	7	guidance	guidance	NN
cord-253196-et1ekgdl	17	8	regarding	regard	VBG
cord-253196-et1ekgdl	17	9	clinical	clinical	JJ
cord-253196-et1ekgdl	17	10	decision	decision	NN
cord-253196-et1ekgdl	17	11	making	make	VBG
cord-253196-et1ekgdl	17	12	both	both	DT
cord-253196-et1ekgdl	17	13	for	for	IN
cord-253196-et1ekgdl	17	14	patients	patient	NNS
cord-253196-et1ekgdl	17	15	with	with	IN
cord-253196-et1ekgdl	17	16	COVID-19	COVID-19	NNP
cord-253196-et1ekgdl	17	17	and	and	CC
cord-253196-et1ekgdl	17	18	those	those	DT
cord-253196-et1ekgdl	17	19	with	with	IN
cord-253196-et1ekgdl	17	20	immune	immune	NN
cord-253196-et1ekgdl	17	21	-	-	HYPH
cord-253196-et1ekgdl	17	22	mediated	mediate	VBN
cord-253196-et1ekgdl	17	23	conditions	condition	NNS
cord-253196-et1ekgdl	17	24	,	,	,
cord-253196-et1ekgdl	17	25	such	such	JJ
cord-253196-et1ekgdl	17	26	as	as	IN
cord-253196-et1ekgdl	17	27	systemic	systemic	JJ
cord-253196-et1ekgdl	17	28	lupus	lupus	NN
cord-253196-et1ekgdl	17	29	erythematosus	erythematosus	NN
cord-253196-et1ekgdl	17	30	(	(	-LRB-
cord-253196-et1ekgdl	17	31	SLE	SLE	NNP
cord-253196-et1ekgdl	17	32	)	)	-RRB-
cord-253196-et1ekgdl	17	33	and	and	CC
cord-253196-et1ekgdl	17	34	rheumatoid	rheumatoid	NN
cord-253196-et1ekgdl	17	35	arthritis	arthritis	NN
cord-253196-et1ekgdl	17	36	(	(	-LRB-
cord-253196-et1ekgdl	17	37	RA	RA	NNP
cord-253196-et1ekgdl	17	38	)	)	-RRB-
cord-253196-et1ekgdl	17	39	,	,	,
cord-253196-et1ekgdl	17	40	and	and	CC
cord-253196-et1ekgdl	17	41	strategies	strategy	NNS
cord-253196-et1ekgdl	17	42	to	to	TO
cord-253196-et1ekgdl	17	43	mitigate	mitigate	VB
cord-253196-et1ekgdl	17	44	further	further	JJ
cord-253196-et1ekgdl	17	45	harm	harm	NN
cord-253196-et1ekgdl	17	46	to	to	IN
cord-253196-et1ekgdl	17	47	these	these	DT
cord-253196-et1ekgdl	17	48	patients	patient	NNS
cord-253196-et1ekgdl	17	49	.	.	.
cord-253196-et1ekgdl	18	1	Data	datum	NNS
cord-253196-et1ekgdl	18	2	to	to	TO
cord-253196-et1ekgdl	18	3	support	support	VB
cord-253196-et1ekgdl	18	4	the	the	DT
cord-253196-et1ekgdl	18	5	use	use	NN
cord-253196-et1ekgdl	18	6	of	of	IN
cord-253196-et1ekgdl	18	7	HCQ	HCQ	NNP
cord-253196-et1ekgdl	18	8	and	and	CC
cord-253196-et1ekgdl	18	9	CQ	CQ	NNP
cord-253196-et1ekgdl	18	10	for	for	IN
cord-253196-et1ekgdl	18	11	COVID-19	COVID-19	NNP
cord-253196-et1ekgdl	18	12	are	be	VBP
cord-253196-et1ekgdl	18	13	limited	limited	JJ
cord-253196-et1ekgdl	18	14	and	and	CC
cord-253196-et1ekgdl	18	15	inconclusive	inconclusive	JJ
cord-253196-et1ekgdl	18	16	.	.	.
cord-253196-et1ekgdl	19	1	The	the	DT
cord-253196-et1ekgdl	19	2	drugs	drug	NNS
cord-253196-et1ekgdl	19	3	have	have	VBP
cord-253196-et1ekgdl	19	4	some	some	DT
cord-253196-et1ekgdl	19	5	in	in	IN
cord-253196-et1ekgdl	19	6	vitro	vitro	FW
cord-253196-et1ekgdl	19	7	activity	activity	NN
cord-253196-et1ekgdl	19	8	against	against	IN
cord-253196-et1ekgdl	19	9	several	several	JJ
cord-253196-et1ekgdl	19	10	viruses	virus	NNS
cord-253196-et1ekgdl	19	11	,	,	,
cord-253196-et1ekgdl	19	12	including	include	VBG
cord-253196-et1ekgdl	19	13	coronaviruses	coronaviruse	NNS
cord-253196-et1ekgdl	19	14	and	and	CC
cord-253196-et1ekgdl	19	15	influenza	influenza	NN
cord-253196-et1ekgdl	19	16	,	,	,
cord-253196-et1ekgdl	19	17	but	but	CC
cord-253196-et1ekgdl	19	18	previous	previous	JJ
cord-253196-et1ekgdl	19	19	randomized	randomized	JJ
cord-253196-et1ekgdl	19	20	trials	trial	NNS
cord-253196-et1ekgdl	19	21	in	in	IN
cord-253196-et1ekgdl	19	22	patients	patient	NNS
cord-253196-et1ekgdl	19	23	with	with	IN
cord-253196-et1ekgdl	19	24	influenza	influenza	NN
cord-253196-et1ekgdl	19	25	have	have	VBP
cord-253196-et1ekgdl	19	26	been	be	VBN
cord-253196-et1ekgdl	19	27	negative	negative	JJ
cord-253196-et1ekgdl	19	28	(	(	-LRB-
cord-253196-et1ekgdl	19	29	4	4	CD
cord-253196-et1ekgdl	19	30	,	,	,
cord-253196-et1ekgdl	19	31	5	5	CD
cord-253196-et1ekgdl	19	32	)	)	-RRB-
cord-253196-et1ekgdl	19	33	.	.	.
cord-253196-et1ekgdl	20	1	In	in	IN
cord-253196-et1ekgdl	20	2	COVID-19	COVID-19	NNP
cord-253196-et1ekgdl	20	3	,	,	,
cord-253196-et1ekgdl	20	4	one	one	CD
cord-253196-et1ekgdl	20	5	small	small	JJ
cord-253196-et1ekgdl	20	6	nonrandomized	nonrandomize	VBN
cord-253196-et1ekgdl	20	7	study	study	NN
cord-253196-et1ekgdl	20	8	from	from	IN
cord-253196-et1ekgdl	20	9	France	France	NNP
cord-253196-et1ekgdl	20	10	(	(	-LRB-
cord-253196-et1ekgdl	20	11	3	3	CD
cord-253196-et1ekgdl	20	12	)	)	-RRB-
cord-253196-et1ekgdl	20	13	(	(	-LRB-
cord-253196-et1ekgdl	20	14	discussed	discuss	VBN
cord-253196-et1ekgdl	20	15	elsewhere	elsewhere	RB
cord-253196-et1ekgdl	20	16	in	in	IN
cord-253196-et1ekgdl	20	17	Annals	Annals	NNP
cord-253196-et1ekgdl	20	18	of	of	IN
cord-253196-et1ekgdl	20	19	Internal	Internal	NNP
cord-253196-et1ekgdl	20	20	Medicine	Medicine	NNP
cord-253196-et1ekgdl	20	21	[	[	-LRB-
cord-253196-et1ekgdl	20	22	6	6	CD
cord-253196-et1ekgdl	20	23	]	]	-RRB-
cord-253196-et1ekgdl	20	24	)	)	-RRB-
cord-253196-et1ekgdl	20	25	demonstrated	demonstrate	VBD
cord-253196-et1ekgdl	20	26	benefit	benefit	NN
cord-253196-et1ekgdl	20	27	but	but	CC
cord-253196-et1ekgdl	20	28	had	have	VBD
cord-253196-et1ekgdl	20	29	serious	serious	JJ
cord-253196-et1ekgdl	20	30	methodological	methodological	JJ
cord-253196-et1ekgdl	20	31	flaws	flaw	NNS
cord-253196-et1ekgdl	20	32	,	,	,
cord-253196-et1ekgdl	20	33	and	and	CC
cord-253196-et1ekgdl	20	34	a	a	DT
cord-253196-et1ekgdl	20	35	follow	follow	VB
cord-253196-et1ekgdl	20	36	-	-	HYPH
cord-253196-et1ekgdl	20	37	up	up	NN
cord-253196-et1ekgdl	20	38	study	study	NN
cord-253196-et1ekgdl	20	39	still	still	RB
cord-253196-et1ekgdl	20	40	lacked	lack	VBD
cord-253196-et1ekgdl	20	41	a	a	DT
cord-253196-et1ekgdl	20	42	control	control	NN
cord-253196-et1ekgdl	20	43	group	group	NN
cord-253196-et1ekgdl	20	44	.	.	.
cord-253196-et1ekgdl	21	1	Yet	yet	RB
cord-253196-et1ekgdl	21	2	,	,	,
cord-253196-et1ekgdl	21	3	another	another	DT
cord-253196-et1ekgdl	21	4	very	very	RB
cord-253196-et1ekgdl	21	5	small	small	JJ
cord-253196-et1ekgdl	21	6	,	,	,
cord-253196-et1ekgdl	21	7	randomized	randomized	JJ
cord-253196-et1ekgdl	21	8	study	study	NN
cord-253196-et1ekgdl	21	9	from	from	IN
cord-253196-et1ekgdl	21	10	China	China	NNP
cord-253196-et1ekgdl	21	11	in	in	IN
cord-253196-et1ekgdl	21	12	patients	patient	NNS
cord-253196-et1ekgdl	21	13	with	with	IN
cord-253196-et1ekgdl	21	14	mild	mild	JJ
cord-253196-et1ekgdl	21	15	to	to	TO
cord-253196-et1ekgdl	21	16	moderate	moderate	JJ
cord-253196-et1ekgdl	21	17	COVID-19	COVID-19	NNP
cord-253196-et1ekgdl	21	18	found	find	VBD
cord-253196-et1ekgdl	21	19	no	no	DT
cord-253196-et1ekgdl	21	20	difference	difference	NN
cord-253196-et1ekgdl	21	21	in	in	IN
cord-253196-et1ekgdl	21	22	recovery	recovery	NN
cord-253196-et1ekgdl	21	23	rates	rate	NNS
cord-253196-et1ekgdl	21	24	(	(	-LRB-
cord-253196-et1ekgdl	21	25	7	7	CD
cord-253196-et1ekgdl	21	26	)	)	-RRB-
cord-253196-et1ekgdl	21	27	.	.	.
cord-253196-et1ekgdl	22	1	Sadly	sadly	RB
cord-253196-et1ekgdl	22	2	,	,	,
cord-253196-et1ekgdl	22	3	reports	report	NNS
cord-253196-et1ekgdl	22	4	of	of	IN
cord-253196-et1ekgdl	22	5	adverse	adverse	JJ
cord-253196-et1ekgdl	22	6	events	event	NNS
cord-253196-et1ekgdl	22	7	have	have	VBP
cord-253196-et1ekgdl	22	8	increased	increase	VBN
cord-253196-et1ekgdl	22	9	,	,	,
cord-253196-et1ekgdl	22	10	with	with	IN
cord-253196-et1ekgdl	22	11	several	several	JJ
cord-253196-et1ekgdl	22	12	countries	country	NNS
cord-253196-et1ekgdl	22	13	reporting	report	VBG
cord-253196-et1ekgdl	22	14	poisonings	poisoning	NNS
cord-253196-et1ekgdl	22	15	and	and	CC
cord-253196-et1ekgdl	22	16	at	at	IN
cord-253196-et1ekgdl	22	17	least	least	JJS
cord-253196-et1ekgdl	22	18	1	1	CD
cord-253196-et1ekgdl	22	19	death	death	NN
cord-253196-et1ekgdl	22	20	reported	report	VBN
cord-253196-et1ekgdl	22	21	in	in	IN
cord-253196-et1ekgdl	22	22	a	a	DT
cord-253196-et1ekgdl	22	23	patient	patient	NN
cord-253196-et1ekgdl	22	24	who	who	WP
cord-253196-et1ekgdl	22	25	drank	drank	VBP
cord-253196-et1ekgdl	22	26	fish	fish	NN
cord-253196-et1ekgdl	22	27	tank	tank	NN
cord-253196-et1ekgdl	22	28	cleaner	cleaner	NN
cord-253196-et1ekgdl	22	29	because	because	IN
cord-253196-et1ekgdl	22	30	of	of	IN
cord-253196-et1ekgdl	22	31	its	-PRON-	PRP$
cord-253196-et1ekgdl	22	32	CQ	CQ	NNP
cord-253196-et1ekgdl	22	33	content	content	NN
cord-253196-et1ekgdl	22	34	.	.	.
cord-253196-et1ekgdl	23	1	Antimalarial	antimalarial	JJ
cord-253196-et1ekgdl	23	2	drugs	drug	NNS
cord-253196-et1ekgdl	23	3	can	can	MD
cord-253196-et1ekgdl	23	4	cause	cause	VB
cord-253196-et1ekgdl	23	5	ventricular	ventricular	JJ
cord-253196-et1ekgdl	23	6	arrhythmias	arrhythmias	RB
cord-253196-et1ekgdl	23	7	,	,	,
cord-253196-et1ekgdl	23	8	QT	qt	NN
cord-253196-et1ekgdl	23	9	prolongation	prolongation	NN
cord-253196-et1ekgdl	23	10	,	,	,
cord-253196-et1ekgdl	23	11	and	and	CC
cord-253196-et1ekgdl	23	12	other	other	JJ
cord-253196-et1ekgdl	23	13	cardiac	cardiac	JJ
cord-253196-et1ekgdl	23	14	toxicity	toxicity	NN
cord-253196-et1ekgdl	23	15	,	,	,
cord-253196-et1ekgdl	23	16	which	which	WDT
cord-253196-et1ekgdl	23	17	may	may	MD
cord-253196-et1ekgdl	23	18	pose	pose	VB
cord-253196-et1ekgdl	23	19	particular	particular	JJ
cord-253196-et1ekgdl	23	20	risk	risk	NN
cord-253196-et1ekgdl	23	21	to	to	TO
cord-253196-et1ekgdl	23	22	critically	critically	RB
cord-253196-et1ekgdl	23	23	ill	ill	JJ
cord-253196-et1ekgdl	23	24	persons	person	NNS
cord-253196-et1ekgdl	23	25	.	.	.
cord-253196-et1ekgdl	24	1	Given	give	VBN
cord-253196-et1ekgdl	24	2	these	these	DT
cord-253196-et1ekgdl	24	3	serious	serious	JJ
cord-253196-et1ekgdl	24	4	potential	potential	JJ
cord-253196-et1ekgdl	24	5	adverse	adverse	JJ
cord-253196-et1ekgdl	24	6	effects	effect	NNS
cord-253196-et1ekgdl	24	7	,	,	,
cord-253196-et1ekgdl	24	8	the	the	DT
cord-253196-et1ekgdl	24	9	hasty	hasty	JJ
cord-253196-et1ekgdl	24	10	and	and	CC
cord-253196-et1ekgdl	24	11	inappropriate	inappropriate	JJ
cord-253196-et1ekgdl	24	12	interpretation	interpretation	NN
cord-253196-et1ekgdl	24	13	of	of	IN
cord-253196-et1ekgdl	24	14	the	the	DT
cord-253196-et1ekgdl	24	15	literature	literature	NN
cord-253196-et1ekgdl	24	16	by	by	IN
cord-253196-et1ekgdl	24	17	public	public	JJ
cord-253196-et1ekgdl	24	18	leaders	leader	NNS
cord-253196-et1ekgdl	24	19	has	have	VBZ
cord-253196-et1ekgdl	24	20	potential	potential	NN
cord-253196-et1ekgdl	24	21	to	to	TO
cord-253196-et1ekgdl	24	22	do	do	VB
cord-253196-et1ekgdl	24	23	serious	serious	JJ
cord-253196-et1ekgdl	24	24	harm	harm	NN
cord-253196-et1ekgdl	24	25	.	.	.
cord-253196-et1ekgdl	25	1	At	at	IN
cord-253196-et1ekgdl	25	2	this	this	DT
cord-253196-et1ekgdl	25	3	time	time	NN
cord-253196-et1ekgdl	25	4	of	of	IN
cord-253196-et1ekgdl	25	5	crisis	crisis	NN
cord-253196-et1ekgdl	25	6	,	,	,
cord-253196-et1ekgdl	25	7	it	-PRON-	PRP
cord-253196-et1ekgdl	25	8	is	be	VBZ
cord-253196-et1ekgdl	25	9	our	-PRON-	PRP$
cord-253196-et1ekgdl	25	10	ethical	ethical	JJ
cord-253196-et1ekgdl	25	11	obligation	obligation	NN
cord-253196-et1ekgdl	25	12	as	as	IN
cord-253196-et1ekgdl	25	13	physicians	physician	NNS
cord-253196-et1ekgdl	25	14	and	and	CC
cord-253196-et1ekgdl	25	15	researchers	researcher	NNS
cord-253196-et1ekgdl	25	16	to	to	TO
cord-253196-et1ekgdl	25	17	organize	organize	VB
cord-253196-et1ekgdl	25	18	and	and	CC
cord-253196-et1ekgdl	25	19	refer	refer	VB
cord-253196-et1ekgdl	25	20	patients	patient	NNS
cord-253196-et1ekgdl	25	21	to	to	IN
cord-253196-et1ekgdl	25	22	expedited	expedite	VBN
cord-253196-et1ekgdl	25	23	,	,	,
cord-253196-et1ekgdl	25	24	well	well	RB
cord-253196-et1ekgdl	25	25	-	-	HYPH
cord-253196-et1ekgdl	25	26	performed	perform	VBN
cord-253196-et1ekgdl	25	27	randomized	randomized	JJ
cord-253196-et1ekgdl	25	28	trials	trial	NNS
cord-253196-et1ekgdl	25	29	that	that	WDT
cord-253196-et1ekgdl	25	30	can	can	MD
cord-253196-et1ekgdl	25	31	clarify	clarify	VB
cord-253196-et1ekgdl	25	32	if	if	IN
cord-253196-et1ekgdl	25	33	,	,	,
cord-253196-et1ekgdl	25	34	when	when	WRB
cord-253196-et1ekgdl	25	35	,	,	,
cord-253196-et1ekgdl	25	36	and	and	CC
cord-253196-et1ekgdl	25	37	for	for	IN
cord-253196-et1ekgdl	25	38	whom	whom	WP
cord-253196-et1ekgdl	25	39	antimalarial	antimalarial	JJ
cord-253196-et1ekgdl	25	40	medications	medication	NNS
cord-253196-et1ekgdl	25	41	are	be	VBP
cord-253196-et1ekgdl	25	42	helpful	helpful	JJ
cord-253196-et1ekgdl	25	43	in	in	IN
cord-253196-et1ekgdl	25	44	COVID-19	COVID-19	NNP
cord-253196-et1ekgdl	25	45	.	.	.
cord-253196-et1ekgdl	26	1	As	as	IN
cord-253196-et1ekgdl	26	2	of	of	IN
cord-253196-et1ekgdl	26	3	this	this	DT
cord-253196-et1ekgdl	26	4	writing	writing	NN
cord-253196-et1ekgdl	26	5	,	,	,
cord-253196-et1ekgdl	26	6	10	10	CD
cord-253196-et1ekgdl	26	7	such	such	JJ
cord-253196-et1ekgdl	26	8	trials	trial	NNS
cord-253196-et1ekgdl	26	9	are	be	VBP
cord-253196-et1ekgdl	26	10	under	under	IN
cord-253196-et1ekgdl	26	11	way	way	NN
cord-253196-et1ekgdl	26	12	,	,	,
cord-253196-et1ekgdl	26	13	and	and	CC
cord-253196-et1ekgdl	26	14	information	information	NN
cord-253196-et1ekgdl	26	15	should	should	MD
cord-253196-et1ekgdl	26	16	be	be	VB
cord-253196-et1ekgdl	26	17	forthcoming	forthcoming	JJ
cord-253196-et1ekgdl	26	18	within	within	IN
cord-253196-et1ekgdl	26	19	weeks	week	NNS
cord-253196-et1ekgdl	26	20	.	.	.
cord-253196-et1ekgdl	27	1	Whereas	whereas	IN
cord-253196-et1ekgdl	27	2	the	the	DT
cord-253196-et1ekgdl	27	3	evidence	evidence	NN
cord-253196-et1ekgdl	27	4	supporting	support	VBG
cord-253196-et1ekgdl	27	5	the	the	DT
cord-253196-et1ekgdl	27	6	use	use	NN
cord-253196-et1ekgdl	27	7	of	of	IN
cord-253196-et1ekgdl	27	8	antimalarial	antimalarial	JJ
cord-253196-et1ekgdl	27	9	medications	medication	NNS
cord-253196-et1ekgdl	27	10	for	for	IN
cord-253196-et1ekgdl	27	11	COVID-19	COVID-19	NNP
cord-253196-et1ekgdl	27	12	is	be	VBZ
cord-253196-et1ekgdl	27	13	equivocal	equivocal	JJ
cord-253196-et1ekgdl	27	14	,	,	,
cord-253196-et1ekgdl	27	15	the	the	DT
cord-253196-et1ekgdl	27	16	evidence	evidence	NN
cord-253196-et1ekgdl	27	17	for	for	IN
cord-253196-et1ekgdl	27	18	the	the	DT
cord-253196-et1ekgdl	27	19	use	use	NN
cord-253196-et1ekgdl	27	20	of	of	IN
cord-253196-et1ekgdl	27	21	these	these	DT
cord-253196-et1ekgdl	27	22	drugs	drug	NNS
cord-253196-et1ekgdl	27	23	to	to	TO
cord-253196-et1ekgdl	27	24	treat	treat	VB
cord-253196-et1ekgdl	27	25	immune	immune	NN
cord-253196-et1ekgdl	27	26	-	-	HYPH
cord-253196-et1ekgdl	27	27	mediated	mediate	VBN
cord-253196-et1ekgdl	27	28	diseases	disease	NNS
cord-253196-et1ekgdl	27	29	is	be	VBZ
cord-253196-et1ekgdl	27	30	not	not	RB
cord-253196-et1ekgdl	27	31	.	.	.
cord-253196-et1ekgdl	28	1	For	for	IN
cord-253196-et1ekgdl	28	2	example	example	NN
cord-253196-et1ekgdl	28	3	,	,	,
cord-253196-et1ekgdl	28	4	HCQ	HCQ	NNP
cord-253196-et1ekgdl	28	5	is	be	VBZ
cord-253196-et1ekgdl	28	6	a	a	DT
cord-253196-et1ekgdl	28	7	cornerstone	cornerstone	NN
cord-253196-et1ekgdl	28	8	of	of	IN
cord-253196-et1ekgdl	28	9	therapy	therapy	NN
cord-253196-et1ekgdl	28	10	for	for	IN
cord-253196-et1ekgdl	28	11	SLE	SLE	NNP
cord-253196-et1ekgdl	28	12	.	.	.
cord-253196-et1ekgdl	29	1	Hydroxychloroquine	Hydroxychloroquine	NNP
cord-253196-et1ekgdl	29	2	can	can	MD
cord-253196-et1ekgdl	29	3	effectively	effectively	RB
cord-253196-et1ekgdl	29	4	treat	treat	VB
cord-253196-et1ekgdl	29	5	disease	disease	NN
cord-253196-et1ekgdl	29	6	manifestations	manifestation	NNS
cord-253196-et1ekgdl	29	7	,	,	,
cord-253196-et1ekgdl	29	8	such	such	JJ
cord-253196-et1ekgdl	29	9	as	as	IN
cord-253196-et1ekgdl	29	10	joint	joint	JJ
cord-253196-et1ekgdl	29	11	pain	pain	NN
cord-253196-et1ekgdl	29	12	and	and	CC
cord-253196-et1ekgdl	29	13	rashes	rash	NNS
cord-253196-et1ekgdl	29	14	;	;	:
cord-253196-et1ekgdl	29	15	reduce	reduce	VB
cord-253196-et1ekgdl	29	16	thrombotic	thrombotic	JJ
cord-253196-et1ekgdl	29	17	events	event	NNS
cord-253196-et1ekgdl	29	18	;	;	:
cord-253196-et1ekgdl	29	19	and	and	CC
cord-253196-et1ekgdl	29	20	prolong	prolong	VB
cord-253196-et1ekgdl	29	21	survival	survival	NN
cord-253196-et1ekgdl	29	22	.	.	.
cord-253196-et1ekgdl	30	1	Of	of	IN
cord-253196-et1ekgdl	30	2	note	note	VB
cord-253196-et1ekgdl	30	3	,	,	,
cord-253196-et1ekgdl	30	4	landmark	landmark	VB
cord-253196-et1ekgdl	30	5	clinical	clinical	JJ
cord-253196-et1ekgdl	30	6	trials	trial	NNS
cord-253196-et1ekgdl	30	7	have	have	VBP
cord-253196-et1ekgdl	30	8	demonstrated	demonstrate	VBN
cord-253196-et1ekgdl	30	9	that	that	IN
cord-253196-et1ekgdl	30	10	the	the	DT
cord-253196-et1ekgdl	30	11	withdrawal	withdrawal	NN
cord-253196-et1ekgdl	30	12	of	of	IN
cord-253196-et1ekgdl	30	13	HCQ	HCQ	NNP
cord-253196-et1ekgdl	30	14	can	can	MD
cord-253196-et1ekgdl	30	15	lead	lead	VB
cord-253196-et1ekgdl	30	16	to	to	IN
cord-253196-et1ekgdl	30	17	flares	flare	NNS
cord-253196-et1ekgdl	30	18	of	of	IN
cord-253196-et1ekgdl	30	19	disease	disease	NN
cord-253196-et1ekgdl	30	20	,	,	,
cord-253196-et1ekgdl	30	21	including	include	VBG
cord-253196-et1ekgdl	30	22	life	life	NN
cord-253196-et1ekgdl	30	23	-	-	HYPH
cord-253196-et1ekgdl	30	24	threatening	threaten	VBG
cord-253196-et1ekgdl	30	25	manifestations	manifestation	NNS
cord-253196-et1ekgdl	30	26	,	,	,
cord-253196-et1ekgdl	30	27	such	such	JJ
cord-253196-et1ekgdl	30	28	as	as	IN
cord-253196-et1ekgdl	30	29	lupus	lupus	NN
cord-253196-et1ekgdl	30	30	nephritis	nephritis	NN
cord-253196-et1ekgdl	30	31	(	(	-LRB-
cord-253196-et1ekgdl	30	32	8)	8)	NNP
cord-253196-et1ekgdl	30	33	.	.	.
cord-253196-et1ekgdl	31	1	The	the	DT
cord-253196-et1ekgdl	31	2	current	current	JJ
cord-253196-et1ekgdl	31	3	shortages	shortage	NNS
cord-253196-et1ekgdl	31	4	of	of	IN
cord-253196-et1ekgdl	31	5	HCQ	HCQ	NNP
cord-253196-et1ekgdl	31	6	have	have	VBP
cord-253196-et1ekgdl	31	7	therefore	therefore	RB
cord-253196-et1ekgdl	31	8	alarmed	alarm	VBN
cord-253196-et1ekgdl	31	9	rheumatologists	rheumatologist	NNS
cord-253196-et1ekgdl	31	10	and	and	CC
cord-253196-et1ekgdl	31	11	patients	patient	NNS
cord-253196-et1ekgdl	31	12	.	.	.
cord-253196-et1ekgdl	32	1	Offices	office	NNS
cord-253196-et1ekgdl	32	2	across	across	IN
cord-253196-et1ekgdl	32	3	the	the	DT
cord-253196-et1ekgdl	32	4	country	country	NN
cord-253196-et1ekgdl	32	5	report	report	VBP
cord-253196-et1ekgdl	32	6	fielding	fielding	NN
cord-253196-et1ekgdl	32	7	calls	call	NNS
cord-253196-et1ekgdl	32	8	from	from	IN
cord-253196-et1ekgdl	32	9	concerned	concerned	JJ
cord-253196-et1ekgdl	32	10	patients	patient	NNS
cord-253196-et1ekgdl	32	11	who	who	WP
cord-253196-et1ekgdl	32	12	are	be	VBP
cord-253196-et1ekgdl	32	13	having	have	VBG
cord-253196-et1ekgdl	32	14	difficulty	difficulty	NN
cord-253196-et1ekgdl	32	15	obtaining	obtain	VBG
cord-253196-et1ekgdl	32	16	their	-PRON-	PRP$
cord-253196-et1ekgdl	32	17	medication	medication	NN
cord-253196-et1ekgdl	32	18	.	.	.
cord-253196-et1ekgdl	33	1	Given	give	VBN
cord-253196-et1ekgdl	33	2	the	the	DT
cord-253196-et1ekgdl	33	3	likelihood	likelihood	NN
cord-253196-et1ekgdl	33	4	that	that	IN
cord-253196-et1ekgdl	33	5	shortages	shortage	NNS
cord-253196-et1ekgdl	33	6	will	will	MD
cord-253196-et1ekgdl	33	7	continue	continue	VB
cord-253196-et1ekgdl	33	8	in	in	IN
cord-253196-et1ekgdl	33	9	the	the	DT
cord-253196-et1ekgdl	33	10	near	near	JJ
cord-253196-et1ekgdl	33	11	term	term	NN
cord-253196-et1ekgdl	33	12	,	,	,
cord-253196-et1ekgdl	33	13	we	-PRON-	PRP
cord-253196-et1ekgdl	33	14	propose	propose	VBP
cord-253196-et1ekgdl	33	15	that	that	IN
cord-253196-et1ekgdl	33	16	manufacturers	manufacturer	NNS
cord-253196-et1ekgdl	33	17	,	,	,
cord-253196-et1ekgdl	33	18	clinicians	clinician	NNS
cord-253196-et1ekgdl	33	19	,	,	,
cord-253196-et1ekgdl	33	20	pharmacies	pharmacy	NNS
cord-253196-et1ekgdl	33	21	,	,	,
cord-253196-et1ekgdl	33	22	health	health	NN
cord-253196-et1ekgdl	33	23	systems	system	NNS
cord-253196-et1ekgdl	33	24	,	,	,
cord-253196-et1ekgdl	33	25	and	and	CC
cord-253196-et1ekgdl	33	26	governmental	governmental	JJ
cord-253196-et1ekgdl	33	27	health	health	NN
cord-253196-et1ekgdl	33	28	agencies	agency	NNS
cord-253196-et1ekgdl	33	29	continue	continue	VBP
cord-253196-et1ekgdl	33	30	to	to	TO
cord-253196-et1ekgdl	33	31	coordinate	coordinate	VB
cord-253196-et1ekgdl	33	32	an	an	DT
cord-253196-et1ekgdl	33	33	aggressive	aggressive	JJ
cord-253196-et1ekgdl	33	34	response	response	NN
cord-253196-et1ekgdl	33	35	to	to	TO
cord-253196-et1ekgdl	33	36	ensure	ensure	VB
cord-253196-et1ekgdl	33	37	that	that	IN
cord-253196-et1ekgdl	33	38	antimalarial	antimalarial	JJ
cord-253196-et1ekgdl	33	39	drug	drug	NN
cord-253196-et1ekgdl	33	40	use	use	NN
cord-253196-et1ekgdl	33	41	is	be	VBZ
cord-253196-et1ekgdl	33	42	appropriately	appropriately	RB
cord-253196-et1ekgdl	33	43	managed	manage	VBN
cord-253196-et1ekgdl	33	44	during	during	IN
cord-253196-et1ekgdl	33	45	the	the	DT
cord-253196-et1ekgdl	33	46	COVID-19	COVID-19	NNP
cord-253196-et1ekgdl	33	47	pandemic	pandemic	NN
cord-253196-et1ekgdl	33	48	.	.	.
cord-253196-et1ekgdl	34	1	First	first	RB
cord-253196-et1ekgdl	34	2	,	,	,
cord-253196-et1ekgdl	34	3	it	-PRON-	PRP
cord-253196-et1ekgdl	34	4	is	be	VBZ
cord-253196-et1ekgdl	34	5	important	important	JJ
cord-253196-et1ekgdl	34	6	to	to	TO
cord-253196-et1ekgdl	34	7	prioritize	prioritize	VB
cord-253196-et1ekgdl	34	8	available	available	JJ
cord-253196-et1ekgdl	34	9	supply	supply	NN
cord-253196-et1ekgdl	34	10	for	for	IN
cord-253196-et1ekgdl	34	11	clinical	clinical	JJ
cord-253196-et1ekgdl	34	12	trials	trial	NNS
cord-253196-et1ekgdl	34	13	evaluating	evaluate	VBG
cord-253196-et1ekgdl	34	14	important	important	JJ
cord-253196-et1ekgdl	34	15	questions	question	NNS
cord-253196-et1ekgdl	34	16	,	,	,
cord-253196-et1ekgdl	34	17	such	such	JJ
cord-253196-et1ekgdl	34	18	as	as	IN
cord-253196-et1ekgdl	34	19	dosing	dosing	NN
cord-253196-et1ekgdl	34	20	,	,	,
cord-253196-et1ekgdl	34	21	prophylaxis	prophylaxis	NN
cord-253196-et1ekgdl	34	22	,	,	,
cord-253196-et1ekgdl	34	23	and	and	CC
cord-253196-et1ekgdl	34	24	treatment	treatment	NN
cord-253196-et1ekgdl	34	25	in	in	IN
cord-253196-et1ekgdl	34	26	COVID-19	COVID-19	NNP
cord-253196-et1ekgdl	34	27	.	.	.
cord-253196-et1ekgdl	35	1	Second	second	JJ
cord-253196-et1ekgdl	35	2	,	,	,
cord-253196-et1ekgdl	35	3	treatment	treatment	NN
cord-253196-et1ekgdl	35	4	interruptions	interruption	NNS
cord-253196-et1ekgdl	35	5	for	for	IN
cord-253196-et1ekgdl	35	6	those	those	DT
cord-253196-et1ekgdl	35	7	with	with	IN
cord-253196-et1ekgdl	35	8	SLE	SLE	NNP
cord-253196-et1ekgdl	35	9	and	and	CC
cord-253196-et1ekgdl	35	10	other	other	JJ
cord-253196-et1ekgdl	35	11	rheumatic	rheumatic	JJ
cord-253196-et1ekgdl	35	12	diseases	disease	NNS
cord-253196-et1ekgdl	35	13	must	must	MD
cord-253196-et1ekgdl	35	14	be	be	VB
cord-253196-et1ekgdl	35	15	prevented	prevent	VBN
cord-253196-et1ekgdl	35	16	,	,	,
cord-253196-et1ekgdl	35	17	because	because	IN
cord-253196-et1ekgdl	35	18	lapses	lapse	NNS
cord-253196-et1ekgdl	35	19	in	in	IN
cord-253196-et1ekgdl	35	20	therapy	therapy	NN
cord-253196-et1ekgdl	35	21	can	can	MD
cord-253196-et1ekgdl	35	22	result	result	VB
cord-253196-et1ekgdl	35	23	in	in	IN
cord-253196-et1ekgdl	35	24	disease	disease	NN
cord-253196-et1ekgdl	35	25	flares	flare	NNS
cord-253196-et1ekgdl	35	26	and	and	CC
cord-253196-et1ekgdl	35	27	strain	strain	VBP
cord-253196-et1ekgdl	35	28	already	already	RB
cord-253196-et1ekgdl	35	29	stretched	stretch	VBN
cord-253196-et1ekgdl	35	30	health	health	NN
cord-253196-et1ekgdl	35	31	care	care	NN
cord-253196-et1ekgdl	35	32	resources	resource	NNS
cord-253196-et1ekgdl	35	33	.	.	.
cord-253196-et1ekgdl	36	1	Third	third	JJ
cord-253196-et1ekgdl	36	2	,	,	,
cord-253196-et1ekgdl	36	3	stakeholders	stakeholder	NNS
cord-253196-et1ekgdl	36	4	should	should	MD
cord-253196-et1ekgdl	36	5	work	work	VB
cord-253196-et1ekgdl	36	6	together	together	RB
cord-253196-et1ekgdl	36	7	to	to	TO
cord-253196-et1ekgdl	36	8	see	see	VB
cord-253196-et1ekgdl	36	9	whether	whether	IN
cord-253196-et1ekgdl	36	10	dispensation	dispensation	NN
cord-253196-et1ekgdl	36	11	of	of	IN
cord-253196-et1ekgdl	36	12	remaining	remain	VBG
cord-253196-et1ekgdl	36	13	supply	supply	NN
cord-253196-et1ekgdl	36	14	to	to	IN
cord-253196-et1ekgdl	36	15	patients	patient	NNS
cord-253196-et1ekgdl	36	16	with	with	IN
cord-253196-et1ekgdl	36	17	COVID-19	covid-19	JJ
cord-253196-et1ekgdl	36	18	makes	make	VBZ
cord-253196-et1ekgdl	36	19	sense	sense	NN
cord-253196-et1ekgdl	36	20	as	as	IN
cord-253196-et1ekgdl	36	21	evidence	evidence	NN
cord-253196-et1ekgdl	36	22	rapidly	rapidly	RB
cord-253196-et1ekgdl	36	23	changes	change	VBZ
cord-253196-et1ekgdl	36	24	.	.	.
cord-253196-et1ekgdl	37	1	Fourth	fourth	JJ
cord-253196-et1ekgdl	37	2	,	,	,
cord-253196-et1ekgdl	37	3	clear	clear	JJ
cord-253196-et1ekgdl	37	4	messages	message	NNS
cord-253196-et1ekgdl	37	5	that	that	WDT
cord-253196-et1ekgdl	37	6	reflect	reflect	VBP
cord-253196-et1ekgdl	37	7	the	the	DT
cord-253196-et1ekgdl	37	8	proper	proper	JJ
cord-253196-et1ekgdl	37	9	interpretations	interpretation	NNS
cord-253196-et1ekgdl	37	10	of	of	IN
cord-253196-et1ekgdl	37	11	available	available	JJ
cord-253196-et1ekgdl	37	12	data	datum	NNS
cord-253196-et1ekgdl	37	13	must	must	MD
cord-253196-et1ekgdl	37	14	be	be	VB
cord-253196-et1ekgdl	37	15	disseminated	disseminate	VBN
cord-253196-et1ekgdl	37	16	with	with	IN
cord-253196-et1ekgdl	37	17	high	high	JJ
cord-253196-et1ekgdl	37	18	frequency	frequency	NN
cord-253196-et1ekgdl	37	19	to	to	TO
cord-253196-et1ekgdl	37	20	counteract	counteract	VB
cord-253196-et1ekgdl	37	21	misinformation	misinformation	NN
cord-253196-et1ekgdl	37	22	,	,	,
cord-253196-et1ekgdl	37	23	including	include	VBG
cord-253196-et1ekgdl	37	24	misleading	misleading	JJ
cord-253196-et1ekgdl	37	25	statements	statement	NNS
cord-253196-et1ekgdl	37	26	or	or	CC
cord-253196-et1ekgdl	37	27	articles	article	NNS
cord-253196-et1ekgdl	37	28	with	with	IN
cord-253196-et1ekgdl	37	29	"	"	``
cord-253196-et1ekgdl	37	30	clickbait	clickbait	JJ
cord-253196-et1ekgdl	37	31	"	"	''
cord-253196-et1ekgdl	37	32	material	material	NN
cord-253196-et1ekgdl	37	33	.	.	.
cord-253196-et1ekgdl	38	1	Finally	finally	RB
cord-253196-et1ekgdl	38	2	,	,	,
cord-253196-et1ekgdl	38	3	safeguards	safeguard	NNS
cord-253196-et1ekgdl	38	4	should	should	MD
cord-253196-et1ekgdl	38	5	be	be	VB
cord-253196-et1ekgdl	38	6	put	put	VBN
cord-253196-et1ekgdl	38	7	into	into	IN
cord-253196-et1ekgdl	38	8	place	place	NN
cord-253196-et1ekgdl	38	9	to	to	TO
cord-253196-et1ekgdl	38	10	discourage	discourage	VB
cord-253196-et1ekgdl	38	11	overutilization	overutilization	NN
cord-253196-et1ekgdl	38	12	by	by	IN
cord-253196-et1ekgdl	38	13	health	health	NN
cord-253196-et1ekgdl	38	14	professionals	professional	NNS
cord-253196-et1ekgdl	38	15	who	who	WP
cord-253196-et1ekgdl	38	16	are	be	VBP
cord-253196-et1ekgdl	38	17	depleting	deplete	VBG
cord-253196-et1ekgdl	38	18	supply	supply	NN
cord-253196-et1ekgdl	38	19	by	by	IN
cord-253196-et1ekgdl	38	20	prescribing	prescribe	VBG
cord-253196-et1ekgdl	38	21	antimalarials	antimalarial	NNS
cord-253196-et1ekgdl	38	22	for	for	IN
cord-253196-et1ekgdl	38	23	preexposure	preexposure	NN
cord-253196-et1ekgdl	38	24	prophylaxis	prophylaxis	NN
cord-253196-et1ekgdl	38	25	.	.	.
cord-253196-et1ekgdl	39	1	Hoarding	hoarding	NN
cord-253196-et1ekgdl	39	2	by	by	IN
cord-253196-et1ekgdl	39	3	health	health	NN
cord-253196-et1ekgdl	39	4	professionals	professional	NNS
cord-253196-et1ekgdl	39	5	for	for	IN
cord-253196-et1ekgdl	39	6	themselves	-PRON-	PRP
cord-253196-et1ekgdl	39	7	and	and	CC
cord-253196-et1ekgdl	39	8	their	-PRON-	PRP$
cord-253196-et1ekgdl	39	9	friends	friend	NNS
cord-253196-et1ekgdl	39	10	or	or	CC
cord-253196-et1ekgdl	39	11	family	family	NN
cord-253196-et1ekgdl	39	12	is	be	VBZ
cord-253196-et1ekgdl	39	13	already	already	RB
cord-253196-et1ekgdl	39	14	occurring	occur	VBG
cord-253196-et1ekgdl	39	15	,	,	,
cord-253196-et1ekgdl	39	16	but	but	CC
cord-253196-et1ekgdl	39	17	state	state	NN
cord-253196-et1ekgdl	39	18	governments	government	NNS
cord-253196-et1ekgdl	39	19	and	and	CC
cord-253196-et1ekgdl	39	20	pharmacy	pharmacy	NN
cord-253196-et1ekgdl	39	21	boards	board	NNS
cord-253196-et1ekgdl	39	22	have	have	VBP
cord-253196-et1ekgdl	39	23	started	start	VBN
cord-253196-et1ekgdl	39	24	to	to	TO
cord-253196-et1ekgdl	39	25	institute	institute	VB
cord-253196-et1ekgdl	39	26	strict	strict	JJ
cord-253196-et1ekgdl	39	27	utilization	utilization	NN
cord-253196-et1ekgdl	39	28	policies	policy	NNS
cord-253196-et1ekgdl	39	29	to	to	TO
cord-253196-et1ekgdl	39	30	prevent	prevent	VB
cord-253196-et1ekgdl	39	31	further	further	JJ
cord-253196-et1ekgdl	39	32	HCQ	hcq	NN
cord-253196-et1ekgdl	39	33	overutilization	overutilization	NN
cord-253196-et1ekgdl	39	34	.	.	.
cord-253196-et1ekgdl	40	1	Meanwhile	meanwhile	RB
cord-253196-et1ekgdl	40	2	,	,	,
cord-253196-et1ekgdl	40	3	multiple	multiple	JJ
cord-253196-et1ekgdl	40	4	manufacturers	manufacturer	NNS
cord-253196-et1ekgdl	40	5	have	have	VBP
cord-253196-et1ekgdl	40	6	already	already	RB
cord-253196-et1ekgdl	40	7	made	make	VBN
cord-253196-et1ekgdl	40	8	critical	critical	JJ
cord-253196-et1ekgdl	40	9	commitments	commitment	NNS
cord-253196-et1ekgdl	40	10	to	to	TO
cord-253196-et1ekgdl	40	11	initiate	initiate	VB
cord-253196-et1ekgdl	40	12	or	or	CC
cord-253196-et1ekgdl	40	13	increase	increase	VB
cord-253196-et1ekgdl	40	14	production	production	NN
cord-253196-et1ekgdl	40	15	of	of	IN
cord-253196-et1ekgdl	40	16	HCQ	HCQ	NNP
cord-253196-et1ekgdl	40	17	.	.	.
cord-253196-et1ekgdl	41	1	What	what	WDT
cord-253196-et1ekgdl	41	2	advice	advice	NN
cord-253196-et1ekgdl	41	3	should	should	MD
cord-253196-et1ekgdl	41	4	clinicians	clinician	NNS
cord-253196-et1ekgdl	41	5	give	give	VB
cord-253196-et1ekgdl	41	6	to	to	IN
cord-253196-et1ekgdl	41	7	patients	patient	NNS
cord-253196-et1ekgdl	41	8	with	with	IN
cord-253196-et1ekgdl	41	9	SLE	SLE	NNP
cord-253196-et1ekgdl	41	10	or	or	CC
cord-253196-et1ekgdl	41	11	RA	RA	NNP
cord-253196-et1ekgdl	41	12	who	who	WP
cord-253196-et1ekgdl	41	13	have	have	VBP
cord-253196-et1ekgdl	41	14	difficulty	difficulty	NN
cord-253196-et1ekgdl	41	15	securing	secure	VBG
cord-253196-et1ekgdl	41	16	HCQ	HCQ	NNP
cord-253196-et1ekgdl	41	17	?	?	.
cord-253196-et1ekgdl	42	1	The	the	DT
cord-253196-et1ekgdl	42	2	pharmacokinetics	pharmacokinetic	NNS
cord-253196-et1ekgdl	42	3	of	of	IN
cord-253196-et1ekgdl	42	4	HCQ	HCQ	NNP
cord-253196-et1ekgdl	42	5	are	be	VBP
cord-253196-et1ekgdl	42	6	an	an	DT
cord-253196-et1ekgdl	42	7	important	important	JJ
cord-253196-et1ekgdl	42	8	consideration	consideration	NN
cord-253196-et1ekgdl	42	9	in	in	IN
cord-253196-et1ekgdl	42	10	answering	answer	VBG
cord-253196-et1ekgdl	42	11	this	this	DT
cord-253196-et1ekgdl	42	12	question	question	NN
cord-253196-et1ekgdl	42	13	.	.	.
cord-253196-et1ekgdl	43	1	With	with	IN
cord-253196-et1ekgdl	43	2	long	long	JJ
cord-253196-et1ekgdl	43	3	-	-	HYPH
cord-253196-et1ekgdl	43	4	term	term	NN
cord-253196-et1ekgdl	43	5	use	use	NN
cord-253196-et1ekgdl	43	6	of	of	IN
cord-253196-et1ekgdl	43	7	HCQ	HCQ	NNP
cord-253196-et1ekgdl	43	8	,	,	,
cord-253196-et1ekgdl	43	9	peak	peak	NN
cord-253196-et1ekgdl	43	10	plasma	plasma	NN
cord-253196-et1ekgdl	43	11	levels	level	NNS
cord-253196-et1ekgdl	43	12	occur	occur	VBP
cord-253196-et1ekgdl	43	13	3	3	CD
cord-253196-et1ekgdl	43	14	to	to	TO
cord-253196-et1ekgdl	43	15	4	4	CD
cord-253196-et1ekgdl	43	16	hours	hour	NNS
cord-253196-et1ekgdl	43	17	after	after	IN
cord-253196-et1ekgdl	43	18	each	each	DT
cord-253196-et1ekgdl	43	19	dose	dose	NN
cord-253196-et1ekgdl	43	20	,	,	,
cord-253196-et1ekgdl	43	21	with	with	IN
cord-253196-et1ekgdl	43	22	a	a	DT
cord-253196-et1ekgdl	43	23	terminal	terminal	JJ
cord-253196-et1ekgdl	43	24	half	half	JJ
cord-253196-et1ekgdl	43	25	-	-	HYPH
cord-253196-et1ekgdl	43	26	life	life	NN
cord-253196-et1ekgdl	43	27	of	of	IN
cord-253196-et1ekgdl	43	28	40	40	CD
cord-253196-et1ekgdl	43	29	to	to	TO
cord-253196-et1ekgdl	43	30	50	50	CD
cord-253196-et1ekgdl	43	31	days	day	NNS
cord-253196-et1ekgdl	43	32	(	(	-LRB-
cord-253196-et1ekgdl	43	33	9	9	CD
cord-253196-et1ekgdl	43	34	)	)	-RRB-
cord-253196-et1ekgdl	43	35	.	.	.
cord-253196-et1ekgdl	44	1	The	the	DT
cord-253196-et1ekgdl	44	2	long	long	JJ
cord-253196-et1ekgdl	44	3	half	half	JJ
cord-253196-et1ekgdl	44	4	-	-	HYPH
cord-253196-et1ekgdl	44	5	life	life	NN
cord-253196-et1ekgdl	44	6	means	mean	VBZ
cord-253196-et1ekgdl	44	7	that	that	IN
cord-253196-et1ekgdl	44	8	brief	brief	JJ
cord-253196-et1ekgdl	44	9	gaps	gap	NNS
cord-253196-et1ekgdl	44	10	in	in	IN
cord-253196-et1ekgdl	44	11	therapy	therapy	NN
cord-253196-et1ekgdl	44	12	,	,	,
cord-253196-et1ekgdl	44	13	on	on	IN
cord-253196-et1ekgdl	44	14	the	the	DT
cord-253196-et1ekgdl	44	15	order	order	NN
cord-253196-et1ekgdl	44	16	of	of	IN
cord-253196-et1ekgdl	44	17	1	1	CD
cord-253196-et1ekgdl	44	18	to	to	IN
cord-253196-et1ekgdl	44	19	2	2	CD
cord-253196-et1ekgdl	44	20	weeks	week	NNS
cord-253196-et1ekgdl	44	21	,	,	,
cord-253196-et1ekgdl	44	22	are	be	VBP
cord-253196-et1ekgdl	44	23	less	less	RBR
cord-253196-et1ekgdl	44	24	concerning	concern	VBG
cord-253196-et1ekgdl	44	25	.	.	.
cord-253196-et1ekgdl	45	1	However	however	RB
cord-253196-et1ekgdl	45	2	,	,	,
cord-253196-et1ekgdl	45	3	longer	long	JJR
cord-253196-et1ekgdl	45	4	treatment	treatment	NN
cord-253196-et1ekgdl	45	5	lapses	lapse	NNS
cord-253196-et1ekgdl	45	6	put	put	VBP
cord-253196-et1ekgdl	45	7	patients	patient	NNS
cord-253196-et1ekgdl	45	8	at	at	IN
cord-253196-et1ekgdl	45	9	risk	risk	NN
cord-253196-et1ekgdl	45	10	for	for	IN
cord-253196-et1ekgdl	45	11	disease	disease	NN
cord-253196-et1ekgdl	45	12	exacerbations	exacerbation	NNS
cord-253196-et1ekgdl	45	13	,	,	,
cord-253196-et1ekgdl	45	14	given	give	VBN
cord-253196-et1ekgdl	45	15	studies	study	NNS
cord-253196-et1ekgdl	45	16	showing	show	VBG
cord-253196-et1ekgdl	45	17	that	that	IN
cord-253196-et1ekgdl	45	18	lower	low	JJR
cord-253196-et1ekgdl	45	19	plasma	plasma	NN
cord-253196-et1ekgdl	45	20	con	con	NN
cord-253196-et1ekgdl	45	21	-	-	:
cord-253196-et1ekgdl	45	22	This	this	DT
cord-253196-et1ekgdl	45	23	article	article	NN
cord-253196-et1ekgdl	45	24	was	be	VBD
cord-253196-et1ekgdl	45	25	published	publish	VBN
cord-253196-et1ekgdl	45	26	at	at	IN
cord-253196-et1ekgdl	45	27	Annals.org	Annals.org	NNP
cord-253196-et1ekgdl	45	28	on	on	IN
cord-253196-et1ekgdl	45	29	31	31	CD
cord-253196-et1ekgdl	45	30	March	March	NNP
cord-253196-et1ekgdl	45	31	2020	2020	CD
cord-253196-et1ekgdl	45	32	.	.	.
cord-253196-et1ekgdl	46	1	centrations	centrations	NNP
cord-253196-et1ekgdl	46	2	of	of	IN
cord-253196-et1ekgdl	46	3	HCQ	HCQ	NNP
cord-253196-et1ekgdl	46	4	correlate	correlate	VBP
cord-253196-et1ekgdl	46	5	with	with	IN
cord-253196-et1ekgdl	46	6	more	more	JJR
cord-253196-et1ekgdl	46	7	SLE	SLE	NNP
cord-253196-et1ekgdl	46	8	disease	disease	NN
cord-253196-et1ekgdl	46	9	activity	activity	NN
cord-253196-et1ekgdl	46	10	(	(	-LRB-
cord-253196-et1ekgdl	46	11	10	10	CD
cord-253196-et1ekgdl	46	12	)	)	-RRB-
cord-253196-et1ekgdl	46	13	.	.	.
cord-253196-et1ekgdl	47	1	In	in	IN
cord-253196-et1ekgdl	47	2	addition	addition	NN
cord-253196-et1ekgdl	47	3	,	,	,
cord-253196-et1ekgdl	47	4	in	in	IN
cord-253196-et1ekgdl	47	5	a	a	DT
cord-253196-et1ekgdl	47	6	well	well	RB
cord-253196-et1ekgdl	47	7	-	-	HYPH
cord-253196-et1ekgdl	47	8	designed	design	VBN
cord-253196-et1ekgdl	47	9	clinical	clinical	JJ
cord-253196-et1ekgdl	47	10	trial	trial	NN
cord-253196-et1ekgdl	47	11	,	,	,
cord-253196-et1ekgdl	47	12	a	a	DT
cord-253196-et1ekgdl	47	13	higher	high	JJR
cord-253196-et1ekgdl	47	14	incidence	incidence	NN
cord-253196-et1ekgdl	47	15	of	of	IN
cord-253196-et1ekgdl	47	16	SLE	SLE	NNP
cord-253196-et1ekgdl	47	17	flares	flare	NNS
cord-253196-et1ekgdl	47	18	was	be	VBD
cord-253196-et1ekgdl	47	19	seen	see	VBN
cord-253196-et1ekgdl	47	20	as	as	RB
cord-253196-et1ekgdl	47	21	soon	soon	RB
cord-253196-et1ekgdl	47	22	as	as	IN
cord-253196-et1ekgdl	47	23	2	2	CD
cord-253196-et1ekgdl	47	24	weeks	week	NNS
cord-253196-et1ekgdl	47	25	after	after	IN
cord-253196-et1ekgdl	47	26	the	the	DT
cord-253196-et1ekgdl	47	27	drug	drug	NN
cord-253196-et1ekgdl	47	28	was	be	VBD
cord-253196-et1ekgdl	47	29	stopped	stop	VBN
cord-253196-et1ekgdl	47	30	(	(	-LRB-
cord-253196-et1ekgdl	47	31	8)	8)	NNP
cord-253196-et1ekgdl	47	32	.	.	.
cord-253196-et1ekgdl	48	1	Patients	patient	NNS
cord-253196-et1ekgdl	48	2	may	may	MD
cord-253196-et1ekgdl	48	3	also	also	RB
cord-253196-et1ekgdl	48	4	wonder	wonder	VB
cord-253196-et1ekgdl	48	5	whether	whether	IN
cord-253196-et1ekgdl	48	6	rationing	ration	VBG
cord-253196-et1ekgdl	48	7	their	-PRON-	PRP$
cord-253196-et1ekgdl	48	8	supply	supply	NN
cord-253196-et1ekgdl	48	9	by	by	IN
cord-253196-et1ekgdl	48	10	halving	halve	VBG
cord-253196-et1ekgdl	48	11	their	-PRON-	PRP$
cord-253196-et1ekgdl	48	12	current	current	JJ
cord-253196-et1ekgdl	48	13	dose	dose	NN
cord-253196-et1ekgdl	48	14	is	be	VBZ
cord-253196-et1ekgdl	48	15	a	a	DT
cord-253196-et1ekgdl	48	16	good	good	JJ
cord-253196-et1ekgdl	48	17	approach	approach	NN
cord-253196-et1ekgdl	48	18	.	.	.
cord-253196-et1ekgdl	49	1	Studies	study	NNS
cord-253196-et1ekgdl	49	2	show	show	VBP
cord-253196-et1ekgdl	49	3	significant	significant	JJ
cord-253196-et1ekgdl	49	4	heterogeneity	heterogeneity	NN
cord-253196-et1ekgdl	49	5	in	in	IN
cord-253196-et1ekgdl	49	6	plasma	plasma	NN
cord-253196-et1ekgdl	49	7	concentrations	concentration	NNS
cord-253196-et1ekgdl	49	8	of	of	IN
cord-253196-et1ekgdl	49	9	HCQ	HCQ	NNP
cord-253196-et1ekgdl	49	10	,	,	,
cord-253196-et1ekgdl	49	11	even	even	RB
cord-253196-et1ekgdl	49	12	when	when	WRB
cord-253196-et1ekgdl	49	13	standard	standard	JJ
cord-253196-et1ekgdl	49	14	doses	dose	NNS
cord-253196-et1ekgdl	49	15	of	of	IN
cord-253196-et1ekgdl	49	16	approximately	approximately	RB
cord-253196-et1ekgdl	49	17	5	5	CD
cord-253196-et1ekgdl	49	18	mg	mg	NNP
cord-253196-et1ekgdl	49	19	/	/	SYM
cord-253196-et1ekgdl	49	20	kg	kg	NNS
cord-253196-et1ekgdl	49	21	are	be	VBP
cord-253196-et1ekgdl	49	22	used	use	VBN
cord-253196-et1ekgdl	49	23	(	(	-LRB-
cord-253196-et1ekgdl	49	24	9	9	CD
cord-253196-et1ekgdl	49	25	)	)	-RRB-
cord-253196-et1ekgdl	49	26	.	.	.
cord-253196-et1ekgdl	50	1	Therefore	therefore	RB
cord-253196-et1ekgdl	50	2	,	,	,
cord-253196-et1ekgdl	50	3	some	some	DT
cord-253196-et1ekgdl	50	4	patients	patient	NNS
cord-253196-et1ekgdl	50	5	may	may	MD
cord-253196-et1ekgdl	50	6	do	do	VB
cord-253196-et1ekgdl	50	7	better	well	RBR
cord-253196-et1ekgdl	50	8	than	than	IN
cord-253196-et1ekgdl	50	9	others	other	NNS
cord-253196-et1ekgdl	50	10	with	with	IN
cord-253196-et1ekgdl	50	11	this	this	DT
cord-253196-et1ekgdl	50	12	approach	approach	NN
cord-253196-et1ekgdl	50	13	.	.	.
cord-253196-et1ekgdl	51	1	The	the	DT
cord-253196-et1ekgdl	51	2	looming	loom	VBG
cord-253196-et1ekgdl	51	3	public	public	JJ
cord-253196-et1ekgdl	51	4	health	health	NN
cord-253196-et1ekgdl	51	5	crisis	crisis	NN
cord-253196-et1ekgdl	51	6	for	for	IN
cord-253196-et1ekgdl	51	7	people	people	NNS
cord-253196-et1ekgdl	51	8	with	with	IN
cord-253196-et1ekgdl	51	9	rheumatic	rheumatic	JJ
cord-253196-et1ekgdl	51	10	diseases	disease	NNS
cord-253196-et1ekgdl	51	11	who	who	WP
cord-253196-et1ekgdl	51	12	will	will	MD
cord-253196-et1ekgdl	51	13	be	be	VB
cord-253196-et1ekgdl	51	14	unable	unable	JJ
cord-253196-et1ekgdl	51	15	to	to	TO
cord-253196-et1ekgdl	51	16	obtain	obtain	VB
cord-253196-et1ekgdl	51	17	HCQ	HCQ	NNP
cord-253196-et1ekgdl	51	18	is	be	VBZ
cord-253196-et1ekgdl	51	19	the	the	DT
cord-253196-et1ekgdl	51	20	result	result	NN
cord-253196-et1ekgdl	51	21	of	of	IN
cord-253196-et1ekgdl	51	22	a	a	DT
cord-253196-et1ekgdl	51	23	perfect	perfect	JJ
cord-253196-et1ekgdl	51	24	storm	storm	NN
cord-253196-et1ekgdl	51	25	of	of	IN
cord-253196-et1ekgdl	51	26	fear	fear	NN
cord-253196-et1ekgdl	51	27	and	and	CC
cord-253196-et1ekgdl	51	28	dissemination	dissemination	NN
cord-253196-et1ekgdl	51	29	of	of	IN
cord-253196-et1ekgdl	51	30	overpromised	overpromise	VBN
cord-253196-et1ekgdl	51	31	data	datum	NNS
cord-253196-et1ekgdl	51	32	.	.	.
cord-253196-et1ekgdl	52	1	However	however	RB
cord-253196-et1ekgdl	52	2	,	,	,
cord-253196-et1ekgdl	52	3	there	there	EX
cord-253196-et1ekgdl	52	4	is	be	VBZ
cord-253196-et1ekgdl	52	5	still	still	RB
cord-253196-et1ekgdl	52	6	time	time	NN
cord-253196-et1ekgdl	52	7	to	to	TO
cord-253196-et1ekgdl	52	8	mitigate	mitigate	VB
cord-253196-et1ekgdl	52	9	the	the	DT
cord-253196-et1ekgdl	52	10	damage	damage	NN
cord-253196-et1ekgdl	52	11	.	.	.
cord-253196-et1ekgdl	53	1	Physicians	physician	NNS
cord-253196-et1ekgdl	53	2	should	should	MD
cord-253196-et1ekgdl	53	3	educate	educate	VB
cord-253196-et1ekgdl	53	4	themselves	-PRON-	PRP
cord-253196-et1ekgdl	53	5	about	about	IN
cord-253196-et1ekgdl	53	6	the	the	DT
cord-253196-et1ekgdl	53	7	strength	strength	NN
cord-253196-et1ekgdl	53	8	of	of	IN
cord-253196-et1ekgdl	53	9	available	available	JJ
cord-253196-et1ekgdl	53	10	data	datum	NNS
cord-253196-et1ekgdl	53	11	regarding	regard	VBG
cord-253196-et1ekgdl	53	12	HCQ	HCQ	NNP
cord-253196-et1ekgdl	53	13	and	and	CC
cord-253196-et1ekgdl	53	14	CQ	CQ	NNP
cord-253196-et1ekgdl	53	15	in	in	IN
cord-253196-et1ekgdl	53	16	treating	treat	VBG
cord-253196-et1ekgdl	53	17	COVID-19	covid-19	NN
cord-253196-et1ekgdl	53	18	.	.	.
cord-253196-et1ekgdl	54	1	They	-PRON-	PRP
cord-253196-et1ekgdl	54	2	should	should	MD
cord-253196-et1ekgdl	54	3	avoid	avoid	VB
cord-253196-et1ekgdl	54	4	misuse	misuse	NN
cord-253196-et1ekgdl	54	5	of	of	IN
cord-253196-et1ekgdl	54	6	HCQ	HCQ	NNP
cord-253196-et1ekgdl	54	7	and	and	CC
cord-253196-et1ekgdl	54	8	CQ	CQ	NNP
cord-253196-et1ekgdl	54	9	for	for	IN
cord-253196-et1ekgdl	54	10	the	the	DT
cord-253196-et1ekgdl	54	11	prophylaxis	prophylaxis	NN
cord-253196-et1ekgdl	54	12	of	of	IN
cord-253196-et1ekgdl	54	13	COVID-19	COVID-19	NNP
cord-253196-et1ekgdl	54	14	,	,	,
cord-253196-et1ekgdl	54	15	because	because	IN
cord-253196-et1ekgdl	54	16	there	there	EX
cord-253196-et1ekgdl	54	17	are	be	VBP
cord-253196-et1ekgdl	54	18	absolutely	absolutely	RB
cord-253196-et1ekgdl	54	19	no	no	DT
cord-253196-et1ekgdl	54	20	data	data	NN
cord-253196-et1ekgdl	54	21	to	to	TO
cord-253196-et1ekgdl	54	22	support	support	VB
cord-253196-et1ekgdl	54	23	this	this	DT
cord-253196-et1ekgdl	54	24	.	.	.
cord-253196-et1ekgdl	55	1	Public	public	JJ
cord-253196-et1ekgdl	55	2	figures	figure	NNS
cord-253196-et1ekgdl	55	3	should	should	MD
cord-253196-et1ekgdl	55	4	refrain	refrain	VB
cord-253196-et1ekgdl	55	5	from	from	IN
cord-253196-et1ekgdl	55	6	promoting	promote	VBG
cord-253196-et1ekgdl	55	7	unproven	unproven	JJ
cord-253196-et1ekgdl	55	8	therapies	therapy	NNS
cord-253196-et1ekgdl	55	9	to	to	IN
cord-253196-et1ekgdl	55	10	the	the	DT
cord-253196-et1ekgdl	55	11	public	public	NN
cord-253196-et1ekgdl	55	12	,	,	,
cord-253196-et1ekgdl	55	13	and	and	CC
cord-253196-et1ekgdl	55	14	instead	instead	RB
cord-253196-et1ekgdl	55	15	provide	provide	VB
cord-253196-et1ekgdl	55	16	clear	clear	JJ
cord-253196-et1ekgdl	55	17	messages	message	NNS
cord-253196-et1ekgdl	55	18	around	around	IN
cord-253196-et1ekgdl	55	19	the	the	DT
cord-253196-et1ekgdl	55	20	uncertainties	uncertainty	NNS
cord-253196-et1ekgdl	55	21	we	-PRON-	PRP
cord-253196-et1ekgdl	55	22	face	face	VBP
cord-253196-et1ekgdl	55	23	in	in	IN
cord-253196-et1ekgdl	55	24	testing	testing	NN
cord-253196-et1ekgdl	55	25	and	and	CC
cord-253196-et1ekgdl	55	26	using	use	VBG
cord-253196-et1ekgdl	55	27	experimental	experimental	JJ
cord-253196-et1ekgdl	55	28	treatments	treatment	NNS
cord-253196-et1ekgdl	55	29	during	during	IN
cord-253196-et1ekgdl	55	30	the	the	DT
cord-253196-et1ekgdl	55	31	current	current	JJ
cord-253196-et1ekgdl	55	32	pandemic	pandemic	NN
cord-253196-et1ekgdl	55	33	,	,	,
cord-253196-et1ekgdl	55	34	including	include	VBG
cord-253196-et1ekgdl	55	35	the	the	DT
cord-253196-et1ekgdl	55	36	risk	risk	NN
cord-253196-et1ekgdl	55	37	for	for	IN
cord-253196-et1ekgdl	55	38	serious	serious	JJ
cord-253196-et1ekgdl	55	39	adverse	adverse	JJ
cord-253196-et1ekgdl	55	40	events	event	NNS
cord-253196-et1ekgdl	55	41	.	.	.
cord-253196-et1ekgdl	56	1	Well	well	RB
cord-253196-et1ekgdl	56	2	-	-	HYPH
cord-253196-et1ekgdl	56	3	done	do	VBN
cord-253196-et1ekgdl	56	4	,	,	,
cord-253196-et1ekgdl	56	5	randomized	randomized	JJ
cord-253196-et1ekgdl	56	6	clinical	clinical	JJ
cord-253196-et1ekgdl	56	7	trials	trial	NNS
cord-253196-et1ekgdl	56	8	should	should	MD
cord-253196-et1ekgdl	56	9	be	be	VB
cord-253196-et1ekgdl	56	10	performed	perform	VBN
cord-253196-et1ekgdl	56	11	urgently	urgently	RB
cord-253196-et1ekgdl	56	12	to	to	TO
cord-253196-et1ekgdl	56	13	test	test	VB
cord-253196-et1ekgdl	56	14	potential	potential	JJ
cord-253196-et1ekgdl	56	15	therapies	therapy	NNS
cord-253196-et1ekgdl	56	16	,	,	,
cord-253196-et1ekgdl	56	17	including	include	VBG
cord-253196-et1ekgdl	56	18	HCQ	HCQ	NNP
cord-253196-et1ekgdl	56	19	.	.	.
cord-253196-et1ekgdl	57	1	In	in	IN
cord-253196-et1ekgdl	57	2	the	the	DT
cord-253196-et1ekgdl	57	3	meantime	meantime	NN
cord-253196-et1ekgdl	57	4	,	,	,
cord-253196-et1ekgdl	57	5	physicians	physician	NNS
cord-253196-et1ekgdl	57	6	should	should	MD
cord-253196-et1ekgdl	57	7	remember	remember	VB
cord-253196-et1ekgdl	57	8	that	that	IN
cord-253196-et1ekgdl	57	9	first	first	RB
cord-253196-et1ekgdl	57	10	,	,	,
cord-253196-et1ekgdl	57	11	we	-PRON-	PRP
cord-253196-et1ekgdl	57	12	must	must	MD
cord-253196-et1ekgdl	57	13	do	do	VB
cord-253196-et1ekgdl	57	14	no	no	DT
cord-253196-et1ekgdl	57	15	harm	harm	NN
cord-253196-et1ekgdl	57	16	to	to	IN
cord-253196-et1ekgdl	57	17	the	the	DT
cord-253196-et1ekgdl	57	18	patients	patient	NNS
cord-253196-et1ekgdl	57	19	with	with	IN
cord-253196-et1ekgdl	57	20	rheumatic	rheumatic	JJ
cord-253196-et1ekgdl	57	21	disease	disease	NN
cord-253196-et1ekgdl	57	22	for	for	IN
cord-253196-et1ekgdl	57	23	whom	whom	WP
cord-253196-et1ekgdl	57	24	high	high	JJ
cord-253196-et1ekgdl	57	25	-	-	HYPH
cord-253196-et1ekgdl	57	26	quality	quality	NN
cord-253196-et1ekgdl	57	27	evidence	evidence	NN
cord-253196-et1ekgdl	57	28	shows	show	VBZ
cord-253196-et1ekgdl	57	29	that	that	IN
cord-253196-et1ekgdl	57	30	HCQ	HCQ	NNP
cord-253196-et1ekgdl	57	31	improves	improve	VBZ
cord-253196-et1ekgdl	57	32	health	health	NN
cord-253196-et1ekgdl	57	33	.	.	.
cord-253196-et1ekgdl	57	34	 	 	_SP
cord-253196-et1ekgdl	58	1	Hydroxychloroquine	Hydroxychloroquine	NNP
cord-253196-et1ekgdl	58	2	,	,	,
cord-253196-et1ekgdl	58	3	a	a	DT
cord-253196-et1ekgdl	58	4	less	less	RBR
cord-253196-et1ekgdl	58	5	toxic	toxic	JJ
cord-253196-et1ekgdl	58	6	derivative	derivative	NN
cord-253196-et1ekgdl	58	7	of	of	IN
cord-253196-et1ekgdl	58	8	chloroquine	chloroquine	NN
cord-253196-et1ekgdl	58	9	,	,	,
cord-253196-et1ekgdl	58	10	is	be	VBZ
cord-253196-et1ekgdl	58	11	effective	effective	JJ
cord-253196-et1ekgdl	58	12	in	in	IN
cord-253196-et1ekgdl	58	13	inhibiting	inhibit	VBG
cord-253196-et1ekgdl	58	14	SARS	SARS	NNP
cord-253196-et1ekgdl	58	15	-	-	HYPH
cord-253196-et1ekgdl	58	16	CoV-2	CoV-2	NNP
cord-253196-et1ekgdl	58	17	infection	infection	NN
cord-253196-et1ekgdl	59	1	in	in	IN
cord-253196-et1ekgdl	59	2	vitro	vitro	FW
cord-253196-et1ekgdl	60	1	In	in	IN
cord-253196-et1ekgdl	60	2	vitro	vitro	FW
cord-253196-et1ekgdl	60	3	antiviral	antiviral	JJ
cord-253196-et1ekgdl	60	4	activity	activity	NN
cord-253196-et1ekgdl	60	5	and	and	CC
cord-253196-et1ekgdl	60	6	projection	projection	NN
cord-253196-et1ekgdl	60	7	of	of	IN
cord-253196-et1ekgdl	60	8	optimized	optimize	VBN
cord-253196-et1ekgdl	60	9	dosing	dosing	NN
cord-253196-et1ekgdl	60	10	design	design	NN
cord-253196-et1ekgdl	60	11	of	of	IN
cord-253196-et1ekgdl	60	12	hydroxychloroquine	hydroxychloroquine	NN
cord-253196-et1ekgdl	60	13	for	for	IN
cord-253196-et1ekgdl	60	14	the	the	DT
cord-253196-et1ekgdl	60	15	treatment	treatment	NN
cord-253196-et1ekgdl	60	16	of	of	IN
cord-253196-et1ekgdl	60	17	severe	severe	JJ
cord-253196-et1ekgdl	60	18	acute	acute	JJ
cord-253196-et1ekgdl	60	19	respiratory	respiratory	JJ
cord-253196-et1ekgdl	60	20	syndrome	syndrome	NN
cord-253196-et1ekgdl	60	21	coronavirus	coronavirus	NN
cord-253196-et1ekgdl	60	22	Hydroxychloroquine	Hydroxychloroquine	NNP
cord-253196-et1ekgdl	60	23	and	and	CC
cord-253196-et1ekgdl	60	24	azithromycin	azithromycin	NNP
cord-253196-et1ekgdl	60	25	as	as	IN
cord-253196-et1ekgdl	60	26	a	a	DT
cord-253196-et1ekgdl	60	27	treatment	treatment	NN
cord-253196-et1ekgdl	60	28	of	of	IN
cord-253196-et1ekgdl	60	29	COVID-19	covid-19	NN
cord-253196-et1ekgdl	60	30	:	:	:
cord-253196-et1ekgdl	60	31	results	result	NNS
cord-253196-et1ekgdl	60	32	of	of	IN
cord-253196-et1ekgdl	60	33	an	an	DT
cord-253196-et1ekgdl	60	34	open	open	JJ
cord-253196-et1ekgdl	60	35	-	-	HYPH
cord-253196-et1ekgdl	60	36	label	label	NN
cord-253196-et1ekgdl	60	37	nonrandomized	nonrandomize	VBN
cord-253196-et1ekgdl	60	38	clinical	clinical	JJ
cord-253196-et1ekgdl	60	39	trial	trial	NN
cord-253196-et1ekgdl	60	40	Chloroquine	Chloroquine	NNP
cord-253196-et1ekgdl	60	41	for	for	IN
cord-253196-et1ekgdl	60	42	influenza	influenza	NN
cord-253196-et1ekgdl	60	43	prevention	prevention	NN
cord-253196-et1ekgdl	60	44	:	:	:
cord-253196-et1ekgdl	60	45	a	a	DT
cord-253196-et1ekgdl	60	46	randomised	randomised	JJ
cord-253196-et1ekgdl	60	47	,	,	,
cord-253196-et1ekgdl	60	48	double	double	JJ
cord-253196-et1ekgdl	60	49	-	-	HYPH
cord-253196-et1ekgdl	60	50	blind	blind	JJ
cord-253196-et1ekgdl	60	51	,	,	,
cord-253196-et1ekgdl	60	52	placebo	placebo	NN
cord-253196-et1ekgdl	60	53	controlled	control	VBN
cord-253196-et1ekgdl	60	54	trial	trial	NN
cord-253196-et1ekgdl	60	55	In	in	IN
cord-253196-et1ekgdl	60	56	vitro	vitro	FW
cord-253196-et1ekgdl	60	57	inhibition	inhibition	NN
cord-253196-et1ekgdl	60	58	of	of	IN
cord-253196-et1ekgdl	60	59	human	human	JJ
cord-253196-et1ekgdl	60	60	influenza	influenza	NN
cord-253196-et1ekgdl	60	61	A	a	DT
cord-253196-et1ekgdl	60	62	virus	virus	NN
cord-253196-et1ekgdl	60	63	replication	replication	NN
cord-253196-et1ekgdl	60	64	by	by	IN
cord-253196-et1ekgdl	60	65	chloroquine	chloroquine	NNP
cord-253196-et1ekgdl	60	66	COVID-19	COVID-19	NNP
cord-253196-et1ekgdl	60	67	Global	Global	NNP
cord-253196-et1ekgdl	60	68	Rheumatology	Rheumatology	NNP
cord-253196-et1ekgdl	60	69	Alliance	Alliance	NNP
cord-253196-et1ekgdl	60	70	.	.	.
cord-253196-et1ekgdl	61	1	A	a	DT
cord-253196-et1ekgdl	61	2	rush	rush	NN
cord-253196-et1ekgdl	61	3	to	to	IN
cord-253196-et1ekgdl	61	4	judgment	judgment	NN
cord-253196-et1ekgdl	61	5	?	?	.
cord-253196-et1ekgdl	62	1	Rapid	rapid	JJ
cord-253196-et1ekgdl	62	2	reporting	reporting	NN
cord-253196-et1ekgdl	62	3	and	and	CC
cord-253196-et1ekgdl	62	4	dissemination	dissemination	NN
cord-253196-et1ekgdl	62	5	of	of	IN
cord-253196-et1ekgdl	62	6	results	result	NNS
cord-253196-et1ekgdl	62	7	and	and	CC
cord-253196-et1ekgdl	62	8	its	-PRON-	PRP$
cord-253196-et1ekgdl	62	9	consequences	consequence	NNS
cord-253196-et1ekgdl	62	10	regarding	regard	VBG
cord-253196-et1ekgdl	62	11	the	the	DT
cord-253196-et1ekgdl	62	12	use	use	NN
cord-253196-et1ekgdl	62	13	of	of	IN
cord-253196-et1ekgdl	62	14	hydroxychloroquine	hydroxychloroquine	NN
cord-253196-et1ekgdl	62	15	for	for	IN
cord-253196-et1ekgdl	62	16	COVID-19	COVID-19	NNP
cord-253196-et1ekgdl	62	17	A	a	DT
cord-253196-et1ekgdl	62	18	pilot	pilot	NN
cord-253196-et1ekgdl	62	19	study	study	NN
cord-253196-et1ekgdl	62	20	of	of	IN
cord-253196-et1ekgdl	62	21	hydroxychloroquine	hydroxychloroquine	NNP
cord-253196-et1ekgdl	62	22	in	in	IN
cord-253196-et1ekgdl	62	23	treatment	treatment	NN
cord-253196-et1ekgdl	62	24	of	of	IN
cord-253196-et1ekgdl	62	25	patients	patient	NNS
cord-253196-et1ekgdl	62	26	with	with	IN
cord-253196-et1ekgdl	62	27	common	common	JJ
cord-253196-et1ekgdl	62	28	coronavirus	coronavirus	NN
cord-253196-et1ekgdl	62	29	disease-19	disease-19	,
cord-253196-et1ekgdl	62	30	(	(	-LRB-
cord-253196-et1ekgdl	62	31	COVID-19	COVID-19	NNP
cord-253196-et1ekgdl	62	32	)	)	-RRB-
cord-253196-et1ekgdl	62	33	A	a	DT
cord-253196-et1ekgdl	62	34	randomized	randomized	JJ
cord-253196-et1ekgdl	62	35	study	study	NN
cord-253196-et1ekgdl	62	36	of	of	IN
cord-253196-et1ekgdl	62	37	the	the	DT
cord-253196-et1ekgdl	62	38	effect	effect	NN
cord-253196-et1ekgdl	62	39	of	of	IN
cord-253196-et1ekgdl	62	40	withdrawing	withdraw	VBG
cord-253196-et1ekgdl	62	41	hydroxychloroquine	hydroxychloroquine	NN
cord-253196-et1ekgdl	62	42	sulfate	sulfate	NN
cord-253196-et1ekgdl	62	43	in	in	IN
cord-253196-et1ekgdl	62	44	systemic	systemic	JJ
cord-253196-et1ekgdl	62	45	lupus	lupus	NN
cord-253196-et1ekgdl	62	46	erythematosus	erythematosus	NN
cord-253196-et1ekgdl	62	47	Mechanisms	Mechanisms	NNPS
cord-253196-et1ekgdl	62	48	of	of	IN
cord-253196-et1ekgdl	62	49	action	action	NN
cord-253196-et1ekgdl	62	50	of	of	IN
cord-253196-et1ekgdl	62	51	hydroxychloroquine	hydroxychloroquine	NNP
cord-253196-et1ekgdl	62	52	and	and	CC
cord-253196-et1ekgdl	62	53	chloroquine	chloroquine	NN
cord-253196-et1ekgdl	62	54	:	:	:
cord-253196-et1ekgdl	62	55	implications	implication	NNS
cord-253196-et1ekgdl	62	56	for	for	IN
cord-253196-et1ekgdl	62	57	rheumatology	rheumatology	NN
cord-253196-et1ekgdl	62	58	Low	low	JJ
cord-253196-et1ekgdl	62	59	blood	blood	NN
cord-253196-et1ekgdl	62	60	concentration	concentration	NN
cord-253196-et1ekgdl	62	61	of	of	IN
cord-253196-et1ekgdl	62	62	hydroxychloroquine	hydroxychloroquine	NN
cord-253196-et1ekgdl	62	63	is	be	VBZ
cord-253196-et1ekgdl	62	64	a	a	DT
cord-253196-et1ekgdl	62	65	marker	marker	NN
cord-253196-et1ekgdl	62	66	for	for	IN
cord-253196-et1ekgdl	62	67	and	and	CC
cord-253196-et1ekgdl	62	68	predictor	predictor	NN
cord-253196-et1ekgdl	62	69	of	of	IN
cord-253196-et1ekgdl	62	70	disease	disease	NN
cord-253196-et1ekgdl	62	71	exacerbations	exacerbation	NNS
cord-253196-et1ekgdl	62	72	in	in	IN
cord-253196-et1ekgdl	62	73	patients	patient	NNS
cord-253196-et1ekgdl	62	74	with	with	IN
cord-253196-et1ekgdl	62	75	systemic	systemic	JJ
cord-253196-et1ekgdl	62	76	lupus	lupus	NN
cord-253196-et1ekgdl	62	77	erythematosus	erythematosus	NN
cord-253196-et1ekgdl	63	1	The	the	DT
cord-253196-et1ekgdl	63	2	authors	author	NNS
cord-253196-et1ekgdl	63	3	thank	thank	VBP
cord-253196-et1ekgdl	63	4	the	the	DT
cord-253196-et1ekgdl	63	5	members	member	NNS
cord-253196-et1ekgdl	63	6	of	of	IN
cord-253196-et1ekgdl	63	7	the	the	DT